ホーム › 肥満症 › カリフォルニア州 › Concord
Concord、CAにおける肥満症の臨床試験
Concordとその周辺地域（約30マイル以内）の拠点で、肥満症に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
被験者募集中第2相
- John Muir Health - Concord /ID# 282469, Concord
- Diablo Clinical Research /ID# 282530, Walnut Creek · 5マイル先
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
被験者募集中第3相
- Diablo Clinical Research, Inc., Walnut Creek · 5マイル先
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
被験者募集中第2相
- Diablo Clinical Research - Flourish Research, Walnut Creek · 5マイル先
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
被験者募集中第3相
- Diablo Clinical Research, Inc., Walnut Creek · 5マイル先
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
被験者募集中第3相
- Diablo Clinical Research, Inc., Walnut Creek · 5マイル先
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
被験者募集中第3相
- Research Site, Walnut Creek · 5マイル先
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
被験者募集中第3相
- Diablo Clinical Research, Inc., Walnut Creek · 5マイル先
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
被験者募集中第3相
- Research Site, Walnut Creek · 5マイル先
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
被験者募集中第3相
- Diablo Clinical Research, Walnut Creek · 5マイル先
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
被験者募集中第3相
- Diablo Clinical Research, Inc., Walnut Creek · 5マイル先
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
被験者募集中第2相
- Diablo Clinical Research, Inc., Walnut Creek · 5マイル先
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
被験者募集中第3相
- Diablo Clinical Research, Inc., Walnut Creek · 5マイル先
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
被験者募集中第2相
- Diablo Clinical Research, Inc., Walnut Creek · 5マイル先
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
被験者募集中第3相
- Diablo Clinical Research, Walnut Creek · 5マイル先
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
被験者募集中第3相
- John Muir Physicians Network, Concord
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
被験者募集中第2相
- Diablo Clinical Research - Flourish Research, Walnut Creek · 5マイル先
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
被験者募集中第3相
- Diablo Clinical Research, Inc., Walnut Creek · 5マイル先
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
被験者募集中第1相
- Diablo Clinical Research, Inc., Walnut Creek · 5マイル先
他の都市における肥満症の試験
- Houston, TX43件の研究
- Chicago, IL41件の研究
- New York City, NY40件の研究
- San Antonio, TX40件の研究
- Washington, DC33件の研究
- Orlando, FL31件の研究
- Dallas, TX30件の研究
- Boston, MA28件の研究
- Las Vegas, NV27件の研究
- Miami, FL27件の研究
- Baltimore, MD25件の研究
- Jacksonville, FL25件の研究
Concordにおける他の研究
- 過体重16件の研究
- 非小細胞肺癌14件の研究
- 大うつ病性障害12件の研究
- 2型糖尿病10件の研究
- 肺がん9件の研究
- 乳がん9件の研究
- 片頭痛8件の研究
- がん（全種類）7件の研究
- 前立腺がん6件の研究
- うつ病6件の研究
- 高血圧5件の研究
- 糖尿病5件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。